Meeting on the Med 2021 | The European cell & gene therapy landscape

Paige Bischoff, Senior VP of Global Public Affairs, Alliance for Regenerative Medicine (ARM), Washington, D.C., provides an overview of the cell and gene therapy sector in Europe. In 2021, there are currently five approved gene therapies and six cell therapies on market in Europe but it is predicted that by 2025, the European Medicines Agency (EMA) will approve 10-20 new cell and gene therapies each year. It is therefore important that current challenges surrounding policy, regulation and reimbursement are addressed in the near future. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.